Earth Science Tech Inc. (OTC: ETST) is capitalizing on its diversified, vertically integrated business model to drive revenue growth and expand its product offerings. By connecting telemedicine consultations, compounding pharmacies, and medication fulfillment within a seamless healthcare ecosystem, the company has achieved an 8% increase in revenue for fiscal 2026, along with improvements in gross profit and net income.
The company operates through several key subsidiaries, including Peak Curative, RxCompound, and Mister Meds, which together form an end-to-end healthcare platform. Its MOCTeledoc platform provides B2B technology and clinical staffing solutions, allowing ETST to generate revenue by supporting other digital health companies while expanding its own reach. This integrated model supports product development and diversification, contributing to the company's financial performance.
Earth Science Tech's core value proposition lies in the seamless integration of patient care, from consultation to fulfillment. By combining compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment, the company creates a cohesive healthcare experience. Additionally, its investments in real estate and asset management activities, along with a consumer products business, further support its operations.
The company's recent financial results highlight the effectiveness of its strategy. Revenue growth of 8% reflects the successful execution of its vertical integration approach, which enables cost efficiencies and cross-selling opportunities across its subsidiaries. The increase in gross profit and net income demonstrates the improved profitability derived from this model.
For more details on Earth Science Tech's business model and recent performance, the full article is available at https://ibn.fm/I1F0R. Additional information about the company can be found on its website at www.EarthScienceTech.com.
Earth Science Tech operates as a diversified holding company focused on the health and wellness sector. The company’s principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company’s healthcare operations are supported by investments in real estate and asset management activities and a consumer products business.
Investors can stay updated with the latest news and updates relating to ETST in the company’s newsroom at https://ibn.fm/ETST.
